Amanta Healthcar
Fundamental Score
Amanta Healthcar Share Price Live NSE/BSE
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of AMANTA across key market metrics for learning purposes.
Positive Indicators
6 factors identified
Strong Operating Margins (21.51%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages. This indicates sustainable profitability potential.
Excellent EPS Growth (20.32% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential and effective capital allocation over extended periods.
Strong Profit Growth Track Record (20.68% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model and effective operational leverage over time.
Strong Cash Generation (₹178.99 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Balanced Promoter Holding (63.56%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
6 factors identified
Premium Valuation Risk (P/E: 40.16x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations. Consider entry timing carefully.
Profit Decline Concern (-17.26%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes. Monitor for recovery signs and management guidance.
Weak Interest Coverage (1.53x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability. Monitor cash flow and debt reduction plans.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.
High P/E Ratio
Observation: Stock may be overvalued relative to earnings.
Analysis: P/E above 30 requires strong growth execution to justify current valuations.
Small Market Cap
Observation: Higher investment risk due to limited size.
Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.
Financial Statements
Comprehensive financial data for Amanta Healthcar
About AMANTA
Business Overview
Amanta Healthcare Limited operates as a pharmaceutical company engaged in developing, manufacturing and marketing a diverse range of sterile liquid products and parenteral products in Africa, Latin America, the United Kingdom, and internationally. The company manufactures its products in three product group segments Large Volume Parenteral, Nipple Head (Single Port), SteriPort (Two Ports), and Small Volume Parenteral. Additionally, it manufactures medical devices and fluid therapy - (IV Fluid), formulations, diluents, ophthalmic, respiratory care and irrigation solutions in therapeutic segment and products, such as irrigation, first-aid solution, and eye lubricants in medical device segment. It also offers a wide range of closure systems, such as nipple head, twist-off, leur-lock, and screw types and container fill-volume ranging from 2ml to 1000 ml. Its markets its products through three strategic business units including national sales, international sales, and product partnering with various foreign and Indian pharmaceutical companies. Amanta Healthcare Limited was formerly known as Marck Biosciences Limited and changed its name to Amanta Healthcare Limited in June 2014. Amanta Healthcare Limited was incorporated in 1994 and is headquartered in Ahmedabad, India.
Company Details
Key Leadership
AMANTA Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of Amanta Healthcar (AMANTA)?
As of 29 Jan 2026, 10:32 am IST, Amanta Healthcar (AMANTA) is currently trading at ₹101.76. The stock has a market capitalization of ₹408.81 (Cr).
Is AMANTA share price Overvalued or Undervalued?
AMANTA is currently trading at a P/E ratio of 40.16x, compared to the industry average of 31.77x. Based on this relative valuation, the stock appears to be Overvalued against its sector peers.
What factors affect the Amanta Healthcar share price?
Key factors influencing AMANTA's price include its quarterly earnings growth (Sales Growth: 6.23%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Amanta Healthcar a good stock for long-term investment?
Amanta Healthcar shows a 5-year Profit Growth of 20.68% and an ROE of 12.99%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.88 before investing.
How does Amanta Healthcar compare with its industry peers?
Amanta Healthcar competes with major peers in the Pharmaceuticals. Investors should compare AMANTA's P/E of 40.16x and ROE of 12.99% against the industry averages to determine its competitive standing.
What is the P/E ratio of AMANTA and what does it mean?
AMANTA has a P/E ratio of 40.16x compared to the industry average of 31.77x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹40 for every ₹1 of annual earnings.
How is AMANTA performing according to Bull Run's analysis?
AMANTA has a Bull Run fundamental score of 44.5/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.
What sector and industry does AMANTA belong to?
AMANTA operates in the Pharmaceuticals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Amanta Healthcar.
What is Return on Equity (ROE) and why is it important for AMANTA?
AMANTA has an ROE of 12.99%, which shows decent profitability but room for improvement. Return on Equity measures how efficiently Amanta Healthcar generates profits from shareholders' equity.
How is AMANTA's debt-to-equity ratio and what does it indicate?
AMANTA has a debt-to-equity ratio of 0.88, which indicates moderate leverage that should be monitored. A ratio below 1.0 generally indicates conservative financing.
What is AMANTA's dividend yield and is it a good dividend stock?
AMANTA offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested.
How has AMANTA grown over the past 5 years?
AMANTA has achieved 5-year growth rates of: Sales Growth 8.30%, Profit Growth 20.68%, and EPS Growth 20.32%.
What is the promoter holding in AMANTA and why does it matter?
Promoters hold 63.56% of AMANTA shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.
What is AMANTA's market capitalization category?
AMANTA has a market capitalization of ₹409 crores, placing it in the Small-cap category.
How volatile is AMANTA stock?
AMANTA has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is the 52-week high and low for AMANTA?
AMANTA has a 52-week high of ₹N/A and low of ₹N/A.
What is AMANTA's operating profit margin trend?
AMANTA has a 5-year average Operating Profit Margin (OPM) of 21.51%, indicating the company's operational efficiency.
How is AMANTA's quarterly performance?
Recent quarterly performance shows YoY Sales Growth of 6.23% and YoY Profit Growth of -17.26%.
What is the institutional holding pattern in AMANTA?
AMANTA has FII holding of 1.00% and DII holding of 11.34%. Significant institutional holding often suggests professional confidence in the stock.